Apyx Medical Corporation (APYX)
USD 1.0
(-13.79%)
USD 1.0
(-13.79%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 52.34 Million USD | 17.61% |
| 2022 | 44.51 Million USD | -8.26% |
| 2021 | 48.51 Million USD | 75.08% |
| 2020 | 27.71 Million USD | -1.57% |
| 2019 | 28.15 Million USD | 68.73% |
| 2018 | 16.68 Million USD | -57.09% |
| 2017 | 38.88 Million USD | 6.16% |
| 2016 | 36.62 Million USD | 24.08% |
| 2015 | 29.52 Million USD | 6.64% |
| 2014 | 27.68 Million USD | 16.99% |
| 2013 | 23.66 Million USD | -14.5% |
| 2012 | 27.67 Million USD | 8.89% |
| 2011 | 25.41 Million USD | 4.87% |
| 2010 | 24.23 Million USD | -10.1% |
| 2009 | 26.95 Million USD | -4.07% |
| 2008 | 28.09 Million USD | -2.37% |
| 2007 | 28.77 Million USD | 7.88% |
| 2006 | 26.67 Million USD | 31.99% |
| 2005 | 20.21 Million USD | -1.39% |
| 2004 | 20.49 Million USD | 23.83% |
| 2003 | 16.55 Million USD | 32.97% |
| 2002 | 12.44 Million USD | 8.38% |
| 2001 | 11.48 Million USD | 15.58% |
| 2000 | 9.93 Million USD | 3.53% |
| 1999 | 9.59 Million USD | 13.69% |
| 1998 | 8.44 Million USD | 14.52% |
| 1997 | 7.37 Million USD | -1.53% |
| 1996 | 7.48 Million USD | 35.59% |
| 1995 | 5.52 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 12.14 Million USD | -16.44% |
| 2024 Q1 | 14.53 Million USD | -0.84% |
| 2023 FY | 52.34 Million USD | 17.61% |
| 2023 Q1 | 12.14 Million USD | -3.72% |
| 2023 Q4 | 14.66 Million USD | -8.21% |
| 2023 Q3 | 15.97 Million USD | 17.72% |
| 2023 Q2 | 13.56 Million USD | 11.75% |
| 2022 Q3 | 9.11 Million USD | -11.45% |
| 2022 FY | 44.51 Million USD | -8.26% |
| 2022 Q4 | 12.61 Million USD | 38.37% |
| 2022 Q2 | 10.29 Million USD | -17.62% |
| 2022 Q1 | 12.49 Million USD | -25.74% |
| 2021 Q4 | 16.82 Million USD | 42.2% |
| 2021 FY | 48.51 Million USD | 75.08% |
| 2021 Q1 | 8.63 Million USD | -24.65% |
| 2021 Q2 | 11.22 Million USD | 29.94% |
| 2021 Q3 | 11.83 Million USD | 5.41% |
| 2020 FY | 27.71 Million USD | -1.57% |
| 2020 Q3 | 6.95 Million USD | 61.87% |
| 2020 Q2 | 4.29 Million USD | -14.03% |
| 2020 Q1 | 4.99 Million USD | -40.38% |
| 2020 Q4 | 11.46 Million USD | 64.85% |
| 2019 Q1 | 5.82 Million USD | -1.74% |
| 2019 FY | 28.15 Million USD | 68.73% |
| 2019 Q4 | 8.38 Million USD | 10.65% |
| 2019 Q3 | 7.57 Million USD | 15.33% |
| 2019 Q2 | 6.56 Million USD | 12.79% |
| 2018 Q1 | 9.91 Million USD | -12.62% |
| 2018 Q3 | 3.67 Million USD | -68.0% |
| 2018 Q4 | 5.92 Million USD | 61.38% |
| 2018 FY | 16.68 Million USD | -57.09% |
| 2018 Q2 | 11.47 Million USD | 15.72% |
| 2017 Q3 | 9.34 Million USD | -4.61% |
| 2017 FY | 38.88 Million USD | 6.16% |
| 2017 Q2 | 9.79 Million USD | 16.81% |
| 2017 Q1 | 8.38 Million USD | -11.64% |
| 2017 Q4 | 11.34 Million USD | 21.41% |
| 2016 Q4 | 9.49 Million USD | -5.65% |
| 2016 Q3 | 10.06 Million USD | 8.26% |
| 2016 Q2 | 9.29 Million USD | 19.55% |
| 2016 Q1 | 7.77 Million USD | -6.26% |
| 2016 FY | 36.62 Million USD | 24.08% |
| 2015 FY | 29.52 Million USD | 6.64% |
| 2015 Q4 | 8.29 Million USD | 6.02% |
| 2015 Q3 | 7.82 Million USD | 7.55% |
| 2015 Q2 | 7.27 Million USD | 18.7% |
| 2015 Q1 | 6.12 Million USD | -17.93% |
| 2014 Q2 | 6.94 Million USD | 7.14% |
| 2014 Q1 | 6.48 Million USD | 5.78% |
| 2014 Q3 | 6.78 Million USD | -2.26% |
| 2014 FY | 27.68 Million USD | 16.99% |
| 2014 Q4 | 7.46 Million USD | 10.0% |
| 2013 Q3 | 5.79 Million USD | -4.1% |
| 2013 FY | 23.66 Million USD | -14.5% |
| 2013 Q4 | 6.12 Million USD | 5.76% |
| 2013 Q2 | 6.04 Million USD | 6.07% |
| 2013 Q1 | 5.69 Million USD | -16.58% |
| 2012 Q2 | 7.44 Million USD | 10.5% |
| 2012 Q3 | 6.67 Million USD | -10.34% |
| 2012 FY | 27.67 Million USD | 8.89% |
| 2012 Q4 | 6.82 Million USD | 2.35% |
| 2012 Q1 | 6.73 Million USD | 9.32% |
| 2011 Q4 | 6.15 Million USD | -1.55% |
| 2011 Q3 | 6.25 Million USD | -8.55% |
| 2011 Q1 | 6.15 Million USD | -1.26% |
| 2011 Q2 | 6.84 Million USD | 11.16% |
| 2011 FY | 25.41 Million USD | 4.87% |
| 2010 FY | 24.23 Million USD | -10.1% |
| 2010 Q3 | 6.5 Million USD | 10.25% |
| 2010 Q4 | 6.23 Million USD | -4.13% |
| 2010 Q2 | 5.89 Million USD | 5.32% |
| 2010 Q1 | 5.59 Million USD | -14.3% |
| 2009 Q1 | 7.21 Million USD | 1.11% |
| 2009 Q4 | 6.53 Million USD | 2.54% |
| 2009 Q3 | 6.37 Million USD | -6.74% |
| 2009 Q2 | 6.83 Million USD | -5.34% |
| 2009 FY | 26.95 Million USD | -4.07% |
| 2008 Q4 | 7.13 Million USD | -2.17% |
| 2008 Q2 | 6.98 Million USD | 4.61% |
| 2008 Q1 | 6.67 Million USD | -6.96% |
| 2008 FY | 28.09 Million USD | -2.37% |
| 2008 Q3 | 7.29 Million USD | 4.44% |
| 2007 Q1 | 6.7 Million USD | -3.17% |
| 2007 Q2 | 7.43 Million USD | 10.95% |
| 2007 Q4 | 7.17 Million USD | -3.79% |
| 2007 Q3 | 7.45 Million USD | 0.27% |
| 2007 FY | 28.77 Million USD | 7.88% |
| 2006 Q2 | 6.74 Million USD | 12.13% |
| 2006 Q3 | 6.99 Million USD | 3.83% |
| 2006 Q4 | 6.92 Million USD | -1.06% |
| 2006 FY | 26.67 Million USD | 31.99% |
| 2006 Q1 | 6.01 Million USD | 11.92% |
| 2005 FY | 20.21 Million USD | -1.39% |
| 2005 Q3 | 5.03 Million USD | -0.38% |
| 2005 Q4 | 5.37 Million USD | 6.59% |
| 2005 Q1 | 4.74 Million USD | -2.52% |
| 2005 Q2 | 5.05 Million USD | 6.63% |
| 2004 FY | 20.49 Million USD | 23.83% |
| 2004 Q1 | 4.74 Million USD | 13.31% |
| 2004 Q2 | 5.25 Million USD | 10.85% |
| 2004 Q3 | 5.61 Million USD | 6.8% |
| 2004 Q4 | 4.86 Million USD | -13.37% |
| 2003 FY | 16.55 Million USD | 32.97% |
| 2003 Q2 | 4.36 Million USD | 19.07% |
| 2003 Q1 | 3.67 Million USD | 15.81% |
| 2003 Q4 | 4.18 Million USD | -3.17% |
| 2003 Q3 | 4.32 Million USD | -1.05% |
| 2002 Q2 | 3.2 Million USD | 5.75% |
| 2002 FY | 12.44 Million USD | 8.38% |
| 2002 Q4 | 3.16 Million USD | 4.04% |
| 2002 Q3 | 3.04 Million USD | -4.9% |
| 2002 Q1 | 3.02 Million USD | -6.68% |
| 2001 Q2 | 2.81 Million USD | 2.99% |
| 2001 Q4 | 3.24 Million USD | 20.93% |
| 2001 Q3 | 2.68 Million USD | -4.78% |
| 2001 Q1 | 2.73 Million USD | -3.66% |
| 2001 FY | 11.48 Million USD | 15.58% |
| 2000 Q1 | 2.17 Million USD | 0.0% |
| 2000 Q2 | 2.43 Million USD | 11.79% |
| 2000 Q3 | 2.49 Million USD | 2.46% |
| 2000 FY | 9.93 Million USD | 3.53% |
| 2000 Q4 | 2.84 Million USD | 14.06% |
| 1999 FY | 9.59 Million USD | 13.69% |
| 1998 FY | 8.44 Million USD | 14.52% |
| 1997 FY | 7.37 Million USD | -1.53% |
| 1996 FY | 7.48 Million USD | 35.59% |
| 1995 FY | 5.52 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 12.05 Million USD | -334.107% |
| BrainsWay Ltd. | 31.78 Million USD | -64.697% |
| Cerus Corporation | 156.36 Million USD | 66.522% |
| Envoy Medical, Inc. | 316 Thousand USD | -16466.139% |
| electroCore, Inc. | 16.03 Million USD | -226.569% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -8028.727% |
| IceCure Medical Ltd | 3.22 Million USD | -1521.214% |
| Inogen, Inc. | 315.66 Million USD | 83.416% |
| OrthoPediatrics Corp. | 148.73 Million USD | 64.803% |
| Lucid Diagnostics Inc. | 2.42 Million USD | -2056.054% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -14242.231% |
| MaxCyte, Inc. | 41.28 Million USD | -26.79% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | -2581.208% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -47168.574% |
| Orthofix Medical Inc. | 746.64 Million USD | 92.989% |
| PAVmed Inc | 2.45 Million USD | -2034.951% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | -132.466% |
| RxSight, Inc. | 89.07 Million USD | 41.232% |
| Sight Sciences, Inc. | 81.05 Million USD | 35.416% |
| SI-BONE, Inc. | 138.88 Million USD | 62.308% |
| TELA Bio, Inc. | 58.45 Million USD | 10.443% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | 72.024% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | -279.313% |
| Acutus Medical, Inc. | 7.16 Million USD | -630.723% |
| Talis Biomedical Corporation | 412 Thousand USD | -12606.068% |
| Spectral AI, Inc. | 18.05 Million USD | -189.926% |
| Nano-X Imaging Ltd. | 9.9 Million USD | -428.511% |
| CVRx, Inc. | 39.29 Million USD | -33.221% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | -5304.013% |
| Bioventus Inc. | 512.34 Million USD | 89.782% |
| Venus Concept Inc. | 76.35 Million USD | 31.439% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | -182.799% |
| LivaNova PLC | 1.15 Billion USD | 95.462% |
| 908 Devices Inc. | 50.22 Million USD | -4.221% |
| Alphatec Holdings, Inc. | 482.26 Million USD | 89.145% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -67846.887% |
| NeuroPace, Inc. | 65.42 Million USD | 19.981% |
| LENSAR, Inc. | 42.16 Million USD | -24.156% |
| Cutera, Inc. | 212.36 Million USD | 75.35% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | -56.931% |
| BioSig Technologies, Inc. | 18 Thousand USD | -290727.778% |
| Anika Therapeutics, Inc. | 166.66 Million USD | 68.59% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | -118.531% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 96.604% |
| Axonics, Inc. | 366.37 Million USD | 85.712% |
| Outset Medical, Inc. | 130.37 Million USD | 59.848% |
| IRIDEX Corporation | 51.86 Million USD | -0.925% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | 61.562% |
| IRadimed Corporation | 65.56 Million USD | 20.154% |
| Tivic Health Systems, Inc. | 1.17 Million USD | -4351.446% |
| INVO Bioscience, Inc. | 3.02 Million USD | -1633.081% |
| Telesis Bio, Inc. | 27.5 Million USD | -90.298% |
| Viemed Healthcare, Inc. | 183 Million USD | 71.395% |
| Varex Imaging Corporation | 811 Million USD | 93.545% |
| Quipt Home Medical Corp. | 221.74 Million USD | 76.392% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | 23.773% |
| Dynatronics Corporation | 32.53 Million USD | -60.906% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | -503.238% |
| Semler Scientific, Inc. | 68.18 Million USD | 23.224% |
| InMode Ltd. | 492.04 Million USD | 89.361% |
| Bruker Corporation | 2.96 Billion USD | 98.234% |
| Cytosorbents Corporation | 36.34 Million USD | -44.016% |
| DexCom, Inc. | 3.62 Billion USD | 98.555% |
| Align Technology, Inc. | 3.86 Billion USD | 98.645% |
| Viveve Medical, Inc. | 6.42 Million USD | -714.644% |
| ZimVie Inc. | 457.43 Million USD | 88.556% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | 72.878% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -47168.574% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | 92.999% |
| Profound Medical Corp. | 7.33 Million USD | -614.075% |
| Insulet Corporation | 1.69 Billion USD | 96.915% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | 58.479% |
| iCAD, Inc. | 17.31 Million USD | -202.281% |
| Nuwellis, Inc. | 8.86 Million USD | -490.58% |
| Biotricity, Inc. | 12.06 Million USD | -333.951% |
| iRhythm Technologies, Inc. | 492.68 Million USD | 89.375% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | -743.658% |
| PAVmed Inc. | 2.45 Million USD | -2034.951% |
| BIOLASE, Inc. | 49.16 Million USD | -6.478% |
| Beyond Air, Inc. | 1.15 Million USD | -4416.739% |
| FONAR Corporation | 102.88 Million USD | 49.118% |
| AxoGen, Inc. | 159.01 Million USD | 67.079% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | 80.924% |
| Inari Medical, Inc. | 493.63 Million USD | 89.395% |
| UFP Technologies, Inc. | 400.07 Million USD | 86.915% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -281346.237% |
| Tenon Medical, Inc. | 2.92 Million USD | -1687.876% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | -668.478% |
| AdaptHealth Corp. | 3.2 Billion USD | 98.364% |
| Sintx Technologies, Inc. | 2.62 Million USD | -1892.729% |
| NanoVibronix, Inc. | 2.28 Million USD | -2192.992% |
| Quanterix Corporation | 122.36 Million USD | 57.22% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | -114.501% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | 73.894% |
| TransMedics Group, Inc. | 241.62 Million USD | 78.334% |
| ReWalk Robotics Ltd. | 13.85 Million USD | -277.862% |
| NeuroMetrix, Inc. | 5.9 Million USD | -787.057% |
| Hyperfine, Inc. | 11.03 Million USD | -374.52% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | 68.302% |
| Biomerica, Inc. | 5.41 Million USD | -866.741% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | -3.536% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | 70.447% |